According to Innovus Pharmaceuticals latest financial reports the total debt is $96.79M, an increase of 24.64% to 2022. At the end of 2022 company had $77.65M total debt. This figure represents the debts and financial obligations that Innovus Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $96.79M | 24.64% |
2022 | $77.65M | 1.15% |
2021 | $76.76M | -64.22% |
2020 | $214.52M | 12.23% |
2019 | $191.15M | - |